The board meeting for Atara Biotherapeutics Inc is scheduled for today, for the purpose of Atara Biotherapeutics Inc Fourth Quarter Earnings Results for 2024See details
Atara Biotherapeutics Inc has a share price target of US$ 10, revenue growth forecast of -74.0%, and profit growth estimate of 31.7% for FY25, based on top 6 analyst calls.
Upgrade Your Plan
You need to upgrade your subscription plan to access this feature